NR4A1 and breast cancer: Although no evidence directly indicated the optimal NAC regimen in hormone receptor (HR)-positive/HER2-negative BC patients, NAC was suggested to be used instead of adjuvant chemotherapy, as patients treated with NAC had similar prognosis as those with adjuvant chemotherapy (5).